Sinopharm
1099.HK
#2273
Rank
NZ$11.10 B
Marketcap
$3.56
Share price
0.23%
Change (1 day)
-25.80%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Market capitalization of Sinopharm (1099.HK)

Market cap: NZ$11.10 Billion

As of September 2024 Sinopharm has a market cap of NZ$11.10 Billion. This makes Sinopharm the world's 2273th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sinopharm from 2009 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$11.10 B-14.07%
2023NZ$12.92 B3.27%
2022NZ$12.51 B26.25%
2021NZ$9.91 B-1.17%
2020NZ$10.02 B-37.67%
2019NZ$16.09 B-13.51%
2018NZ$18.60 B10.38%
2017NZ$16.85 B2.4%
2016NZ$16.46 B1.35%
2015NZ$16.24 B30.14%
2014NZ$12.47 B39.09%
2013NZ$8.97 B-2.14%
2012NZ$9.16 B24.06%
2011NZ$7.39 B-28%
2010NZ$10.26 B-8.01%
2009NZ$11.15 B

End of Day market cap according to different sources

On Sep 19th, 2024 the market cap of Sinopharm was reported to be:

NZ$10.97 Billion
by Yahoo Finance info icon info icon
NZ$10.97 Billion
by CompaniesMarketCap info icon info icon